BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 17, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

I-020502: Phase IIa data

Twelve-month data from a German Phase lla trial in 10 burn patients receiving autologous meshed skin grafts showed that KUR-212 produced a shorter time to wound closure and similar long-term scar appearance outcomes compared with stapled sites. There was...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >